New
HealthMore in Health →
Researchers test a new approach to severe stimulant-related agitation
A preclinical study from Marshall University suggests a dexmedetomidine-ketamine combination may control methamphetamine-induced agitation with deeper early sedation and fewer side effects than high-dose dexmedetomidine,
Key Takeaways
- A Marshall University preclinical study tested a dexmedetomidine-ketamine approach for methamphetamine-induced agitation.
- The combination nearly completely controlled agitation in rats and showed less intense side effects than high-dose dexmedetomidine.
DE
DT Editorial AI··via medicalxpress.com